Online Purchasing Account You are logged on as Guest. Login Register a New Account Shopping cart (Empty)

AM-251

Cannabinoid receptor ligand



BML-CR108-0010	10 mg	310.00 USD
Do you need bulk/larger quantities?

Replaces Prod. #: ALX-270-239

Cannabinoid CB₁ receptor antagonist (K_i=7.5 nM). Displays a high level of selectivity (306-fold) for CB₁ over CB₂ receptors. Structurally related to the cannabinoid receptor (CB) antagonist SR 141716A.

Product Details

Formula:	C₂₂H₂₁Cl₂IN₄O

MW:	555.2

CAS:	183232-66-8

Purity:	≥98% (HPLC)

Identity:	Determined by ¹H-NMR.

Appearance:	White to Off White

Solubility:	Soluble in DMSO, 100% ethanol or dimethyl formamide.

Shipping:	Ambient Temperature

Long Term Storage:	+4°C

Use/Stability:	Store, as supplied, at room temperature for up to 1 year. Store solutions at -20°C for up to 3 months.

Regulatory Status:	RUO - Research Use Only

Please mouse over

Product Literature References

AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion: A.P. Chambers et al.; Br. J. Pharmacol. 147, 109 (2006), Abstract;

Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice: R.J. Rodgers et al.; Behav. Pharmacol. 16, 405 (2005), Abstract;

The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis: K. Matsuda et al.; Tohoku. J. Exp. Med. 207, 99 (2005), Abstract;

The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats: P.J. McLaughlin et al.; Psychopharmacology (Berl) 180, 286 (2005), Abstract;

Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat: A.P. Chambers et al.; Physiol. Behav. 82, 863 (2004), Abstract;

Inhibition of voltage-sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brain: C. Liao et al.; Basic Clin. Pharmacol. Toxicol. 94, 73 (2004), Abstract;

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists: R. Lan et al.; J. Med. Chem. 42, 769 (1999), Abstract;

Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors: S. J. Gatley et al.; Life. Sci. 61, PL 191-7 (1997), Abstract;